Last updated: April 24, 2026

Application No. 19/397,818

Untitled Application

Unknown

Filed

1600

Examiner

CARR, DEBORAH D

Art Unit

1691

Tech Center

ABREXA PHARMACEUTICALS, INC.

Assignee

Abrexa Pharmaceuticals Inc.

OA Round

1 (Non-Final)

Interview Optional

— +0.8% interview lift. This examiner has a relatively high allow rate; a written response may suffice.

Based on 1057 resolved cases, 2023–2026

Examiner Intelligence

CARR, DEBORAH D View full profile →

Grants 82% — above average

Career Allow Rate

863 granted / 1057 resolved

+21.6% vs TC avg

Minimal +1% lift

Without

With

+0.8%

Interview Lift

resolved cases with interview

Typical timeline

2y 7m

Avg Prosecution

36 currently pending

Career history

1093

Total Applications

across all art units

Statute-Specific Performance

§101

3.0%

-37.0% vs TC avg

§103

31.2%

-8.8% vs TC avg

§102

28.1%

-11.9% vs TC avg

§112

25.8%

-14.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1057 resolved cases

Prosecution Timeline

1600

Application Filed

Jan 24, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/928,567

Patent 12600692

PRODUCTION AND PURIFICATION OF ACETIC ACID

2y 5m to grant Granted Apr 14, 2026

18/025,527

Patent 12600693

METHOD FOR PRODUCING COMPOUND

2y 5m to grant Granted Apr 14, 2026

18/038,031

Patent 12590055

PROCESS FOR PRODUCING ISOCYANATES

2y 5m to grant Granted Mar 31, 2026

17/787,519

Patent 12582598

A TOPICAL ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING ZILEUTON

2y 5m to grant Granted Mar 24, 2026

17/998,891

Patent 12582627

MCT FORMULATIONS FOR IMPROVING COGNITIVE FUNCTIONS

2y 5m to grant Granted Mar 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

82%

Grant Probability

82%

With Interview (+0.8%)

2y 7m

Median Time to Grant

Low

PTA Risk

Based on 1057 resolved cases by this examiner. Grant probability derived from career allow rate.